# NEOPROFEN
> **NDA021903** · New Drug Application · Sponsor: RECORDATI RARE · Approved 2006-04-13
## Drug
- **FDA Application Number:** NDA021903
- **Application type:** New Drug Application
- **Brand name:** NEOPROFEN
- **Generic name:** IBUPROFEN LYSINE
- **Active ingredients:** IBUPROFEN LYSINE
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** RECORDATI RARE
- **Manufacturer:** Recordati Rare Diseases Inc.
- **First approval:** 2006-04-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021903)
---
*MORVS · CC0 1.0*